Related references
Note: Only part of the references are listed.Long-Term Clinical Outcome of First Recurrence Skull Base Meningiomas
Yuki Kuranari et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Prognostic value of preoperative neutrophil to lymphocyte ratio is superior to systemic immune inflammation index for survival in patients with Glioblastoma
Yajuan Lv et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2019)
Neutrophil/Lymphocyte Ratio Is an Independent Prognostic Factor in Elderly Patients with High-Grade Gliomas
Youjun Gan et al.
WORLD NEUROSURGERY (2019)
Can Systemic Inflammatory Markers Be Used to Predict the Pathological Grade of Meningioma Before Surgery?
Minhua Lin et al.
WORLD NEUROSURGERY (2019)
Cytotoxic T Cells and their Activation Status are Independent Prognostic Markers in Meningiomas
Carmen Rapp et al.
CLINICAL CANCER RESEARCH (2019)
The significance of preoperative hematological inflammatory markers in patients with meningiomas
Ruo-Fei Liang et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2019)
Immunological and vascular characteristics in cavernous sinus meningioma
Kenzo Kosugi et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2019)
Prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio for breast cancer patients: An updated meta-analysis of 17079 individuals
Wanying Guo et al.
CANCER MEDICINE (2019)
Prognostic impact of neutrophil-to-lymphocyte ratio in gliomas: a systematic review and meta-analysis
Yu-ying Lei et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2019)
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012-2016
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2019)
Persistent restoration to the immunosupportive tumor microenvironment in glioblastoma by bevacizumab
Ryota Tamura et al.
CANCER SCIENCE (2019)
Tumor-associated macrophage infiltration in meningioma
Dustin T. Proctor et al.
NEURO-ONCOLOGY ADVANCES (2019)
Influence of neutrophil-lymphocyte ratio in prognosis of glioblastoma multiforme
Marta Lopes et al.
JOURNAL OF NEURO-ONCOLOGY (2018)
Diagnostic value of preoperative inflammatory markers in patients with glioma: a multicenter cohort study
Shi-hao Zheng et al.
JOURNAL OF NEUROSURGERY (2018)
Lymphocyte-Related Inflammation and Immune-Based Scores Predict Prognosis of Chordoma Patients After Radical Resection
Wenhao Hu et al.
TRANSLATIONAL ONCOLOGY (2018)
Preoperative neutrophil-lymphocyte ratio correlated with glioma grading and glioblastoma survival
Weiji Weng et al.
NEUROLOGICAL RESEARCH (2018)
Impact of neutrophil-lymphocyte ratio on long-term outcome in patients with craniopharyngioma
Jing Zhang et al.
MEDICINE (2018)
Preoperative Hematologic Inflammatory Markers as Prognostic Factors in Patients with Glioma
Yifeng Bao et al.
WORLD NEUROSURGERY (2018)
PROGNOSTIC SIGNIFICANCE OF PREOPERATIVE NEUTROPHIL- TO-LYMPHOCYTE RATIO AND PLATELET-TO-LYMPHOCYTE RATIO IN PATIENTS WITH GLIOMA
Junli Wang et al.
EXCLI JOURNAL (2018)
Longitudinal experience with WHO Grade III (anaplastic) meningiomas at a single institution
Suresh K. Balasubramanian et al.
JOURNAL OF NEURO-ONCOLOGY (2017)
Elevated preoperative neutrophil-to-lymphocyte ratio as a predictor of worse survival after resection in patients with brain metastasis
Koichi Mitsuya et al.
JOURNAL OF NEUROSURGERY (2017)
Prognostic significance of preoperative neutrophilia on recurrence-free survival in meningioma
Shirin Karimi et al.
NEURO-ONCOLOGY (2017)
Preoperative inflammation markers and IDH mutation status predict glioblastoma patient survival
Peng-Fei Wang et al.
ONCOTARGET (2017)
WHO grade 1 meningioma recurrence: Are location and Simpson grade still relevant?
Mathew J. Gallagher et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2016)
Benign meningiomas (WHO Grade I) with atypical histological features: correlation of histopathological features with clinical outcomes
Ariel E. Marciscano et al.
JOURNAL OF NEUROSURGERY (2016)
Neutrophil to Lymphocyte Ratio as a Predictive Marker of Vestibular Schwannoma Growth
Georgios Kontorinis et al.
OTOLOGY & NEUROTOLOGY (2016)
Association of preoperative levels of selected blood inflammatory markers with prognosis in gliomas
Raushan Auezova et al.
ONCOTARGETS AND THERAPY (2016)
Pre-treatment neutrophil-to-lymphocyte ratio is associated with neutrophil and T-cell infiltration and predicts clinical outcome in patients with glioblastoma
Sheng Han et al.
BMC CANCER (2015)
Prognostic value of lymphocyte-to-monocyte ratio in patients with solid tumors: A systematic review and meta-analysis
Tomohiro F. Nishijima et al.
CANCER TREATMENT REVIEWS (2015)
Benign versus atypical meningiomas: Risk factors predicting recurrence
Arkadiusz Nowak et al.
NEUROLOGIA I NEUROCHIRURGIA POLSKA (2015)
Mitotic Index is an Independent Predictor of Recurrence-Free Survival in Meningioma
Adriana Olar et al.
BRAIN PATHOLOGY (2015)
Factors impacting survival following second surgery in patients with glioblastoma in the temozolomide treatment era, incorporating neutrophil/lymphocyte ratio and time to first progression
Mairead G. McNamara et al.
JOURNAL OF NEURO-ONCOLOGY (2014)
Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis
Arnoud J. Templeton et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
Factors affecting peritumoral brain edema in meningioma: special histological subtypes with prominently extensive edema
Tadashi Osawa et al.
JOURNAL OF NEURO-ONCOLOGY (2013)
The association of pre-treatment neutrophil to lymphocyte ratio with overall survival in patients with glioblastoma multiforme
R. M. Bambury et al.
JOURNAL OF NEURO-ONCOLOGY (2013)
The immune cell infiltrate populating meningiomas is composed of mature, antigen-experienced T and B cells
Liangjuan Fang et al.
NEURO-ONCOLOGY (2013)
Significance of Simpson grading system in modern meningioma surgery: integration of the grade with MIB-1 labeling index as a key to predict the recurrence of WHO Grade I meningiomas Clinical article
Soichi Oya et al.
JOURNAL OF NEUROSURGERY (2012)
Opportunities for clinical research in meningioma
Michael A. Vogelbaum et al.
JOURNAL OF NEURO-ONCOLOGY (2010)
A comparison of World Health Organization tumor grades at recurrence in patients with non-skull base and skull base meningiomas Clinical article
Susan L. McGovern et al.
JOURNAL OF NEUROSURGERY (2010)
Ki67 in breast cancer: prognostic and predictive potential
Rinat Yerushalmi et al.
LANCET ONCOLOGY (2010)
Recurrence and regrowth of benign meningiomas
Satoshi Nakasu et al.
BRAIN TUMOR PATHOLOGY (2009)
MIB1 proliferation index in meningiomas: does it predict recurrence? A clinicopathological study
A Tyagi et al.
BRITISH JOURNAL OF NEUROSURGERY (2004)
The Ki-67 proliferation antigen in meningiomas. Experience in 600 cases
F Roser et al.
ACTA NEUROCHIRURGICA (2004)
Share Paper
